Michael D Pak

Array ( [id] => 9581965 [patent_doc_number] => 08771967 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-07-08 [patent_title] => 'Immunomodulation of functional T cell assays for diagnosis of infectious or autoimmune disorders' [patent_app_type] => utility [patent_app_number] => 13/297818 [patent_app_country] => US [patent_app_date] => 2011-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 8588 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 113 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13297818 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9015935 [patent_doc_number] => 20130230899 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-09-05 [patent_title] => 'THERAPEUTIC AGENT FOR ARTERIOSCLEROSIS OR ARTERIOSCLEROTIC DISEASE, AND DIAGNOSTIC AGENT FOR ARTERIOSCLEROSIS OR ARTERIOSCLEROTIC DISEASE' [patent_app_type] => utility [patent_app_number] => 13/884215 [patent_app_country] => US [patent_app_date] => 2011-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 16322 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13884215 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9268745 [patent_doc_number] => 20140023662 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-01-23 [patent_title] => 'NON-ANTAGONISTIC EGFR-BINDING MOLECULES AND IMMUNOCONJUGATES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/882059 [patent_app_country] => US [patent_app_date] => 2011-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 31738 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13882059 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9095527 [patent_doc_number] => 20130274838 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-10-17 [patent_title] => 'OPTICAL CONTROL OF CARDIAC FUNCTION' [patent_app_type] => utility [patent_app_number] => 13/880236 [patent_app_country] => US [patent_app_date] => 2011-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 14509 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13880236 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9273333 [patent_doc_number] => 08637263 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2014-01-28 [patent_title] => 'Assay for determination of compounds having anti-emetic activity' [patent_app_type] => utility [patent_app_number] => 13/274106 [patent_app_country] => US [patent_app_date] => 2011-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 8870 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 175 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13274106 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9003160 [patent_doc_number] => 20130224285 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-29 [patent_title] => 'ESTROGEN RECEPTOR ALPHA POLYPEPTIDE SEQUENCE, DIAGNOSTIC AND THERAPEUTIC APPLICATIONS THEREOF' [patent_app_type] => utility [patent_app_number] => 13/876428 [patent_app_country] => US [patent_app_date] => 2011-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 19828 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13876428 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8951418 [patent_doc_number] => 20130197199 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-01 [patent_title] => 'ANTIBODY AGAINST HUMAN PROSTAGLANDIN E2 RECEPTOR EP4' [patent_app_type] => utility [patent_app_number] => 13/876763 [patent_app_country] => US [patent_app_date] => 2011-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 20249 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13876763 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8950567 [patent_doc_number] => 20130196348 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-01 [patent_title] => 'NEUROPEPTIDE Q AS MODULATOR OF GPCR GALR2 AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/876447 [patent_app_country] => US [patent_app_date] => 2011-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 26443 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13876447 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8586146 [patent_doc_number] => 20130004968 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-01-03 [patent_title] => 'Sepsis blood biomarker system' [patent_app_type] => utility [patent_app_number] => 13/200233 [patent_app_country] => US [patent_app_date] => 2011-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 11346 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13200233 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8270511 [patent_doc_number] => 08212018 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-07-03 [patent_title] => 'Variable lymphocyte receptors, related polypeptides and nucleic acids, and uses thereof' [patent_app_type] => utility [patent_app_number] => 13/229020 [patent_app_country] => US [patent_app_date] => 2011-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 13 [patent_no_of_words] => 26477 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13229020 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9937133 [patent_doc_number] => 08986937 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-03-24 [patent_title] => 'Compositions and methods for detecting autoantibodies' [patent_app_type] => utility [patent_app_number] => 13/228705 [patent_app_country] => US [patent_app_date] => 2011-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 10 [patent_no_of_words] => 11348 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 226 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13228705 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7783888 [patent_doc_number] => 20120045444 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-23 [patent_title] => 'Treatment for Neoplastic Diseases' [patent_app_type] => utility [patent_app_number] => 13/215464 [patent_app_country] => US [patent_app_date] => 2011-08-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5545 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0045/20120045444.pdf [firstpage_image] =>[orig_patent_app_number] => 13215464 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8317290 [patent_doc_number] => 08232063 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-07-31 [patent_title] => 'H+-gated ion channel' [patent_app_type] => utility [patent_app_number] => 13/211898 [patent_app_country] => US [patent_app_date] => 2011-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 18 [patent_no_of_words] => 11415 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13211898 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8042253 [patent_doc_number] => 20120070857 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-22 [patent_title] => 'ELECTROPHYSIOLOGICAL ASSAYS USING OOCYTES THAT EXPRESS HUMAN ENaC AND THE USE OF PHENAMIL TO IMPROVE THE EFFECT OF ENaC ENHANCERS IN ASSAYS USING MEMBRANE POTENTIAL REPORTING DYES' [patent_app_type] => utility [patent_app_number] => 13/206656 [patent_app_country] => US [patent_app_date] => 2011-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 21492 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0070/20120070857.pdf [firstpage_image] =>[orig_patent_app_number] => 13206656 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8829223 [patent_doc_number] => 20130130268 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-05-23 [patent_title] => 'EPITOPES OF THE HUMAN PDGF RECEPTOR ABLE TO BIND HUMAN AUTO-ANTIBODIES, ANTIBODIES AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/812764 [patent_app_country] => US [patent_app_date] => 2011-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 6895 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13812764 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8289777 [patent_doc_number] => 20120178104 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-12 [patent_title] => 'Spatial Biomarker of Disease and Detection of Spatial Organization of Cellular Receptors' [patent_app_type] => utility [patent_app_number] => 13/194577 [patent_app_country] => US [patent_app_date] => 2011-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 22636 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13194577 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9413331 [patent_doc_number] => 08697367 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-04-15 [patent_title] => 'Markers for detection of complications resulting from in utero encounters' [patent_app_type] => utility [patent_app_number] => 13/193421 [patent_app_country] => US [patent_app_date] => 2011-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 39727 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 105 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13193421 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7733686 [patent_doc_number] => 20120016000 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-19 [patent_title] => 'METHOD TO ASSAY PHOSPHOLIPID AND TRIGLYCERIDE TRANSFER ACTIVITY OF MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN' [patent_app_type] => utility [patent_app_number] => 13/183835 [patent_app_country] => US [patent_app_date] => 2011-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 7221 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0016/20120016000.pdf [firstpage_image] =>[orig_patent_app_number] => 13183835 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9530322 [patent_doc_number] => 08754195 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-06-17 [patent_title] => 'Antibody formulations' [patent_app_type] => utility [patent_app_number] => 13/175522 [patent_app_country] => US [patent_app_date] => 2011-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 30368 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13175522 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10020662 [patent_doc_number] => 09063140 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-06-23 [patent_title] => 'Whitefly ecdysone receptor nucleic acids, polypeptides, and uses thereof' [patent_app_type] => utility [patent_app_number] => 13/174620 [patent_app_country] => US [patent_app_date] => 2011-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 30708 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 130 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13174620 [rel_patent_id] =>[rel_patent_doc_number] =>)